AtG can help when standard therapy fails
How it works

Determine plasma levels of RF-1 in metastatic kidney patients

Selection of patients with higher RF-1 levels

Treatment with RF-1 inhibitor
With our technology we will improve the lives of patients affected by cancer therapeutic resistance
Advantages

Fills a medical need

Fast prediction of patients response

New tool for clinical decision-making processes to be made regarding treatments.